The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Abstract Details
|
Activity Number:
|
457
|
|
Type:
|
Topic Contributed
|
|
Date/Time:
|
Wednesday, August 3, 2011 : 8:30 AM to 10:20 AM
|
|
Sponsor:
|
Biopharmaceutical Section
|
| Abstract - #302631 |
|
Title:
|
Minimum Statistical Standards for Biomarker Development
|
|
Author(s):
|
Jae Kyun Lee*+
|
|
Companies:
|
University of Virginia
|
|
Address:
|
POBOX 800717, Charlottesville, VA, 22911,
|
|
Keywords:
|
biomarker ;
SBIG ;
StatBDS
|
|
Abstract:
|
Development of predictive molecular and clinicopathological biomarkers for disease diagnosis, prognosis and therapeutic response is critical for continuous efforts in personalized medicine. Recent biomarker developments have become extremely challenging statistically, especially since a vast amount of molecular and clinicopathological data are commonly utilized in these developments. The so-called Statistical Biomarker Interest Group (SBIG), consisting of >40 statistical biomarker scientists from FDA, industry, and academia, was formed in 2010. SBIG is currently making efforts to derive a consensus opinion on the most essential statistical issues and criteria for biomarker development, termed as "Minimum Statistical Biomarker Development Standards (StatBDS)."
|
The address information is for the authors that have a + after their name.
Authors who are presenting talks have a * after their name.
Back to the full JSM 2011 program
|
2011 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.